MedTrace Logo

Children's Healthy Living Community Randomized Trial

NCT01881373 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9840

Last updated 2024-03-04

Study results available
· View outcomes & findings →

Summary

The goal is to build social/cultural, political/economic, and physical/built environments that will promote active play and intake of healthy food to prevent young child obesity in the Pacific Region. Our methods will support local culture in order to achieve this goal in these remote, underserved native populations. CHL will engage the community, and focus on capacity building and sustainable environmental change.

The focus of the CHL community-based program is to promote healthy eating and to increase physical activity. In order to demonstrate effectiveness, the investigators will recruit and measure children in six communities selected in each of our jurisdictions in the Pacific. These represent intervention communities, comparison communities, and temporal communities.

Conditions

  • Obesity
  • Acanthosis Nigricans
  • Central Obesity

Interventions

OTHER

CHL program

Multiple component environmentally focused program designed with community engagement.

OTHER

Delayed Optimized CHL program

CHL programs with fewer component and shorter duration.

Sponsors & Collaborators

  • University of Guam

    collaborator OTHER

  • Northern Marianas College

    collaborator UNKNOWN

  • University of Alaska Fairbanks

    collaborator OTHER

  • American Samoa Community College

    collaborator UNKNOWN

  • University of Hawaii

    lead OTHER

Principal Investigators

  • Rachel Novotny, PhD · University of Hawaii

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2015-08-31
Completion
2020-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01881373 on ClinicalTrials.gov